Insider Buying: ECO Animal Health Group (LON:EAH) Insider Purchases £19,999.32 in Stock

ECO Animal Health Group plc (LON:EAHGet Free Report) insider David Hallas acquired 18,348 shares of the stock in a transaction on Thursday, December 4th. The stock was bought at an average price of GBX 109 per share, with a total value of £19,999.32.

ECO Animal Health Group Trading Up 3.9%

Shares of ECO Animal Health Group stock traded up GBX 4.10 on Thursday, hitting GBX 108.10. The stock had a trading volume of 108,437 shares, compared to its average volume of 87,270. The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81. ECO Animal Health Group plc has a one year low of GBX 50 and a one year high of GBX 114. The stock has a market cap of £72.96 million, a price-to-earnings ratio of 44.49 and a beta of -0.05. The stock’s 50-day simple moving average is GBX 89.35 and its two-hundred day simple moving average is GBX 76.46.

ECO Animal Health Group (LON:EAHGet Free Report) last posted its quarterly earnings results on Monday, December 1st. The company reported GBX (0.54) EPS for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Analyst Ratings Changes

Separately, Shore Capital increased their target price on shares of ECO Animal Health Group from GBX 150 to GBX 160 and gave the stock a “buy” rating in a report on Tuesday. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, ECO Animal Health Group currently has a consensus rating of “Buy” and an average target price of GBX 160.

Read Our Latest Report on ECO Animal Health Group

About ECO Animal Health Group

(Get Free Report)

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

See Also

Receive News & Ratings for ECO Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ECO Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.